School of Biological and Health Systems Engineering
Our molecular, cellular, and tissue engineering faculty specialize in developing advanced biomaterials designed to regenerate damaged tissues, pioneering molecular and cellular therapies, and creating targeted drug delivery systems tailored specifically for challenging cancer types that are traditionally difficult to treat. Their research aims to innovate therapeutic strategies that enhance patient outcomes and quality of life.
Andrews' lab utilizes neural organoids, transplantation models and omics approaches to study human brain development and disease.
Nikkhah's laboratory is currently focused on the integration of innovative biomaterial and microscale technologies to create biomimetic model tissue constructs for regenerative medicine and disease modeling applications.
Pizziconi heads the Laboratory of BioInspired Complex Adaptive Systems. His expertise is bioresponsive and biomimetic materials.
The Smith group specializes in developing novel imaging technologies and multiomic biomarker discovery towards applications in women’s health and mental illness.
Stabenfeldt leads her research team in developing regenerative medicine strategies for acute neural injury. Her expertise areas include regenerative medicine, targeted theranostics and neurotrauma.
Vernon develops smart polymer systems and virtual drug delivery models for medical treatments including brain aneurysm embolization, drug delivery systems, and advanced liquid embolics.
Wachs’ current research focuses on engineering treatments for and developing models of chronic orthopedic pain.
Weaver's expertise lies in integrating biomaterials, drug delivery, and tissue and immune engineering for the development of functional and immune-protected tissue and cell grafts.
